Technical University Of Munich

This study tests if dupilumab, a drug already approved for eczema, can help people with nummular eczema—a chronic, itchy skin disease. About 70 adults with moderate-to-severe symptoms will receive either dupilumab or a placebo. The goal is to see if the drug reduces skin inflamma…

This study tests whether glycerol phenylbutyrate (GPB) can slow corticobasal syndrome (CBS), a rare and fast-progressing brain disease. About 32 adults with CBS will receive GPB or a placebo for 26 weeks. The main goal is to see if GPB lowers a marker of nerve damage called NfL i…